The use of live attenuated influenza vaccine (LAIV) in healthcare personnel (HCP): guidance from the Society for Healthcare Epidemiology of America (SHEA)

Infect Control Hosp Epidemiol. 2012 Oct;33(10):981-3. doi: 10.1086/667772.

Abstract

Because of the live viral backbone of live attenuated influenza vaccine (LAIV), questions have arisen regarding infection control precautions and restrictions surrounding its use in healthcare personnel (HCP). This document provides guidance from the Society for Healthcare Epidemiology of America regarding use of LAIV in HCP and the infection control precautions that are recommended with its use in this population.

MeSH terms

  • Health Personnel*
  • Humans
  • Infection Control / methods
  • Influenza A virus / immunology*
  • Influenza B virus / immunology*
  • Influenza Vaccines / therapeutic use*
  • Influenza, Human / prevention & control*
  • Influenza, Human / virology
  • Practice Guidelines as Topic
  • United States
  • Vaccines, Attenuated / therapeutic use
  • Virus Shedding

Substances

  • Influenza Vaccines
  • Vaccines, Attenuated